Analyzing ICON Public (NASDAQ:ICLR) and Izotropic (OTCMKTS:IZOZF)
their valuation, analyst recommendations, institutional ownership, earnings, dividends, risk and profitability. Both medical companies but ICON Public is better based on stronger valuation, analyst recommendations, institutional ownership, earnings, dividends, and profitability.
Which is the best stock? We will compare the two companies on the basis of their valuation, earnings and dividends, analyst ratings, and risk.
Analyst Ratings
MarketBeat.com has provided a summary of the current ratings for ICON Public & Izotropic.
Sell Ratings
Hold Ratings
Buy Ratings
Strong Buy Ratings
Rating Score
ICON Public
0
1
9
0
2.90
Izotropic
0
0
0
0
N/A
ICON Public currently has a consensus target price of $257.30. This indicates a potential upside growth of 9.90%. Analysts believe ICON Public has a higher potential upside than Izotropic.
Institutional and Insider Ownership
Institutional investors hold 92.3% ICON Public shares. Insiders own 44.0% ICON Public shares. Strong institutional ownership indicates that hedge funds, endowments, and large money managers believe the stock will perform better than the market in the long run.
Profitability
This table compares ICON Public's net margins with Izotropic, as well as their return on equity (ROE) and return on assets.
Net Margins
Return on Equity
Return on Assets
ICON Public
6.52%
11.16%
5.45%
Izotropic
N/A
N/A
N/A
Earnings and Value
This table compares ICON Public's revenue, earnings-per-share and valuation with Izotropic.
Gross Revenue
Price/Sales Ratio
Net Income
Earnings per Share
Price to Earnings Ratio
ICON Public
$7.74 billion
2.48
$55.30 Million
$6.18
37.88
Izotropic
N/A
N/A
N/A
N/A
N/A
ICON Public's revenue and earnings are higher than Izotropic.
You can read more about it here:
ICON Public is superior to Izotropic in 8 out of 8 factors when comparing the two stocks.
ICON Public
Get Rating
)
ICON Public Limited Company is a clinical research company that provides development and commercialization outsourcing services in Ireland, Europe, the United States and internationally. The company is a leader in strategic development, management and analysis of programs to support the various stages of clinical development from compound selection through Phase I-IV studies. It provides clinical development services including all phases of the development process, peri- and post-approval, data solutions and site access services. Clinical research services include biostatistics and clinical operations. It also offers laboratory services to its customers, such as bioanalytical services, vaccines, good manufacturing practices, central laboratory services and biomarker services. It also offers early phase, language and medical imaging solutions, commercial positioning and strategic solutions as well as consulting and contract staffing. The company provides services to the pharmaceutical, biotechnology and medical device industries as well as public and government health organizations. ICON Public Limited Company, incorporated in Dublin in 1990, is the company's headquarters.
About Izotropic
Get Rating
)
Izotropic Corporation is a MedTech firm that commercializes breast cancer diagnostic products. It develops and sells breast CT imaging system and 3D CT platform for early detection and diagnosis. MarketBeat.com offers a FREE daily email newsletter
.